Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Makris

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 5, 2008
Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parametersJoost J van Veen, Alex Gatt, Peter C Cooper, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2011
Protamine reversal of low molecular weight heparin: clinically effective?Joost J van Veen, Rhona M Maclean, Kingsley K Hampton, et al.
The Lancet. Haematology|August 8, 2024
Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines ListGlenn F Pierce, Brian O'Mahony, Radoslaw Kaczmarek, et al.
The New England Journal of Medicine|August 11, 2021
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and ThrombosisSue Pavord, Marie Scully, Beverley J Hunt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 11, 2024
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD)Wolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 19, 2024
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challengesWolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2024
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)Kathelijn Fischer, Riitta Lassila, Flora Peyvandi, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2022
Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwideChristopher Reilly-Stitt, Ian Jennings, Steve Kitchen, et al.
Thrombosis and Haemostasis|August 9, 2006
Establishment of the 1st International Genetic Reference Panel for Factor V Leiden, human gDNAElaine Gray, J Ross Hawkins, Marion Morrison, et al.
Blood|September 25, 2012
Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panelBan B Dawood, Gillian C Lowe, Marie Lordkipanidzé, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 5, 2008
Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parametersJoost J van Veen, Alex Gatt, Peter C Cooper, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2011
Protamine reversal of low molecular weight heparin: clinically effective?Joost J van Veen, Rhona M Maclean, Kingsley K Hampton, et al.
The Lancet. Haematology|August 8, 2024
Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines ListGlenn F Pierce, Brian O'Mahony, Radoslaw Kaczmarek, et al.
The New England Journal of Medicine|August 11, 2021
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and ThrombosisSue Pavord, Marie Scully, Beverley J Hunt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 11, 2024
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD)Wolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 19, 2024
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challengesWolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2024
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)Kathelijn Fischer, Riitta Lassila, Flora Peyvandi, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2022
Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwideChristopher Reilly-Stitt, Ian Jennings, Steve Kitchen, et al.
Thrombosis and Haemostasis|August 9, 2006
Establishment of the 1st International Genetic Reference Panel for Factor V Leiden, human gDNAElaine Gray, J Ross Hawkins, Marion Morrison, et al.
Blood|September 25, 2012
Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panelBan B Dawood, Gillian C Lowe, Marie Lordkipanidzé, et al.
Pageof 9